26
2016
-
05
In vitro diagnostic industry rapid development independent laboratory market space is large
Recently, the medical information network released data show that in 2015 China's in vitro diagnostic (IVD) market size of about 36.3 billion yuan, the industry growth rate of 30%. The industry as a whole presents the characteristics of frequent technological innovation, variety diversification and high quality requirements. In vitro diagnosis involves biochemical diagnosis and molecular diagnosis of laboratory medicine. Compared with the overall growth rate of the pharmaceutical industry into a single-digit development status quo, in vitro diagnostics still enjoy a high-speed growth trend of 20% to 30%, the high business climate is expected to continue.
Author:
Recently, the medical information network released data show that in 2015 China's in vitro diagnostic (IVD) market size of about 36.3 billion yuan, the industry growth rate of 30%. The industry as a whole presents the characteristics of frequent technological innovation, variety diversification and high quality requirements. In vitro diagnosis involves biochemical diagnosis and molecular diagnosis of laboratory medicine. Compared with the overall growth rate of the pharmaceutical industry into a single-digit development status quo, in vitro diagnostics still enjoy a high-speed growth trend of 20% to 30%, the high business climate is expected to continue.
The agency believes that the molecular diagnostic industry is regulated by the State Food and Drug Administration and the Health Planning Commission and other departments, and the industry threshold and standardization are constantly improving. At the same time, the regulatory authorities have gradually liberalized and supported the industry as a whole. The good industry structure has brought high profit margins for the development of the industry, with a gross profit margin of 58%. At present, the IVD industry has sufficient supply of raw materials, small price fluctuations, and strong industry transfer cost capacity. It is expected that in the next few years, molecular diagnosis will maintain a growth rate of more than 20%.
In vitro diagnosis, or IVD, refers to products and services that obtain clinical diagnostic information by testing human samples (blood, body fluids, tissues, etc.) outside the human body, and then judge diseases or body functions. In addition, the systematization of clinical testing can improve the accuracy of clinical testing results, which is the requirement of clinical laboratory quality management and the inevitable trend of IVD development.
It is worth noting that independent diagnostic laboratories developed rapidly in 2015, with a growth rate of over 30%, and the market share of the four major independent diagnostic laboratories exceeded 65%. Among them, the listed companies Dean Diagnostics and Daan Gene accounted for two seats. Dean Diagnoses that the company's commercial revenue in 2015 was 0.763 billion yuan, up 52% year-on-year. From November last year to January this year, 56% of Jinhua Furuida, 51% of Xinjiang Yuanding and 51% of Yunnan Shengshi Kehua were acquired respectively, accelerating channel integration. The independent laboratory of Daan Gene has basically completed the layout and is expected to turn losses into profits in 2016.
In fact, the business development of independent medical laboratories in my country lags far behind that of developed countries, with a market share of only 5%. Compared with Australia's 80% market share and Japan's 67% market share, there is huge room for future development. The agency expects independent laboratories to maintain a growth rate of more than 30% and is expected to add 20 billion market space.
Related News
2023-01-13
2022-11-23
Contact Information
Address: Floor 5, Building 1, No.1 Xingchang Road, Science and Technology Park, Changping District, Beijing